Register For Our Mailing List

Register to receive our free weekly newsletter including editorials.

Home / 161

Hybrids: the good, the bad and the ugly

Hybrids are the cane toads of the financial markets, and just as cane toads have evolved to survive in a range of climates, hybrids have adapted to changing regulatory and interest rate environments. The similarities do not end there because like cane toads, hybrids have good, bad and ugly characteristics.

The good

Hybrid margins (the difference between the interest earned and the benchmark interest rate) are higher than what has been offered historically and are attractive, especially in a very low interest rate environment (the bank bill benchmark rate is currently about 2%). Interest is calculated quarterly and all ASX-listed bank hybrids are floating rate. Back when interest rates were high, hybrid margins were relatively skinny. NAB’s National Income Securities (ASX: NABHA) were issued in financial ‘pre Jurassic times’ in 1999 with a margin over the bank bill benchmark of just 1.25% pa and investors were happy to invest at that level.

Figure 1: Paying better returns – hybrid spreads widen

Source: Bond Adviser

In more recent times, margins have increased. All of ANZ’s five listed hybrids were issued in the 3% range. But returns hit a low point in October 2014 with the CBA Perls VII issue offering a margin of just 2.8% over the benchmark. This issue was a big one with CBA raising $3 billion. Since then investors have sold down hybrids and the price of Perls VII trades well below its $100 par value and is often in the high $80s to low $90s, pushing the margin up for new investors to over 5%.

While CBA wins the prize for the lowest margin hybrid on issue, Perls VIII issued in February 2016 was at the other end of the scale with a 5.2% pa margin, perhaps rewarding tolerant investors for past mispricing. This issue has tended to trade above par, implying investors would be satisfied with a lower rate.

The most recent Westpac issue, Capital Notes 4 (ASX: WBCPG), settled at a 4.9% margin and raised $1.45 billion, well over the targeted $750 million, a good result for investors and the bank. Next horse out of the gates was NAB with margin set at 4.95%, a small sweetener over the Westpac issue.

Separately, ANZ has announced a USD hybrid, a first for any Australian bank. Considerable work would have gone into marketing the issue, but they will reap the benefits of expanding their investor base and having issuance in another currency. The fixed coupon in USD is 6.5% and the cost of the issuance is rumoured to be higher once swapped back into Australian dollars as a premium for a new market is fairly typical.

The success of the heavily-oversubscribed ANZ deal will open another market for the majors and could mean reduced issuance here. Depending on demand, this could push hybrid prices higher. The issue will provide an international comparison of margins and terms for our own insular, domestic market.

The bad

The complexity and range of terms and conditions in hybrids makes them hard to assess. Comparing older hybrids that were more debt-like with new ones is extremely difficult. For example, the ANZPC and WBCPC were issued soon after Basel III was implemented and contain capital trigger clauses but not a non-viability clause that was mandatory from early 2013. So what extra return do you require over and above the margins on those securities to compensate for the additional risk?

The non-viability clause is important for investors to understand, and we have prepared this fact sheet for those requiring more information.

The ugly

The conversion terms and conditions especially those following a ‘loss absorption’ event are ugly. Practically every hybrid has variations to these terms and percentage conversion rates can differ, even if issued by the same bank. It’s part of the evolution of hybrids.

Investors should be aware of multiple possible outcomes, and follow the share price of the bank as it determines conversion or not. For example the NABPD requires that “The VWAP (volume-weighted average price) of ordinary shares on 25th business day immediately preceding (but not including) a potential mandatory conversion date must be greater than 56% of the issue date VWAP”. All new hybrids have similar clauses. It means hybrids aren’t set and forget investments and you need to keep track of share price movements. Those hybrids issued when share prices are high are at greater risk of non-conversion. For an example of the complexity, consider the terms of the NABPD conversion.

NABPD conversion conditions

Source: National Australia Bank, NABPD prospectus, page 24

The success of all the recent hybrid issues shows investors are willing to accept these ‘ugly’ terms and conditions as they search for yield, but in financial markets, there’s no reward without risk. Remember that cane toads were originally introduced to Australia to control a major pest, the sugar cane beetle, and many decades later, that has turned very ugly indeed.

 

Elizabeth Moran is Director of Client Education and Research at FIIG Securities. Click on this link for a free copy of FIIG’s 2016 Smart Income Report designed for income-seeking investors. This article is general information and does not consider the circumstances of any individual.

 

RELATED ARTICLES

Last call on bank hybrids

The future of bank hybrids is open to question

Hybrids alongside corporate bonds a good balance

banner

Most viewed in recent weeks

Vale Graham Hand

It’s with heavy hearts that we announce Firstlinks’ co-founder and former Managing Editor, Graham Hand, has died aged 66. Graham was a legendary figure in the finance industry and here are three tributes to him.

Australian stocks will crush housing over the next decade, one year on

Last year, I wrote an article suggesting returns from ASX stocks would trample those from housing over the next decade. One year later, this is an update on how that forecast is going and what's changed since.

Avoiding wealth transfer pitfalls

Australia is in the early throes of an intergenerational wealth transfer worth an estimated $3.5 trillion. Here's a case study highlighting some of the challenges with transferring wealth between generations.

Taxpayers betrayed by Future Fund debacle

The Future Fund's original purpose was to meet the unfunded liabilities of Commonwealth defined benefit schemes. These liabilities have ballooned to an estimated $290 billion and taxpayers continue to be treated like fools.

Australia’s shameful super gap

ASFA provides a key guide for how much you will need to live on in retirement. Unfortunately it has many deficiencies, and the averages don't tell the full story of the growing gender superannuation gap.

Looking beyond banks for dividend income

The Big Four banks have had an extraordinary run and it’s left income investors with a conundrum: to stick with them even though they now offer relatively low dividend yields and limited growth prospects or to look elsewhere.

Latest Updates

Investment strategies

9 lessons from 2024

Key lessons include expensive stocks can always get more expensive, Bitcoin is our tulip mania, follow the smart money, the young are coming with pitchforks on housing, and the importance of staying invested.

Investment strategies

Time to announce the X-factor for 2024

What is the X-factor - the largely unexpected influence that wasn’t thought about when the year began but came from left field to have powerful effects on investment returns - for 2024? It's time to select the winner.

Shares

Australian shares struggle as 2020s reach halfway point

It’s halfway through the 2020s decade and time to get a scorecheck on the Australian stock market. The picture isn't pretty as Aussie shares are having a below-average decade so far, though history shows that all is not lost.

Shares

Is FOMO overruling investment basics?

Four years ago, we introduced our 'bubbles' chart to show how the market had become concentrated in one type of stock and one view of the future. This looks at what, if anything, has changed, and what it means for investors.

Shares

Is Medibank Private a bargain?

Regulatory tensions have weighed on Medibank's share price though it's unlikely that the government will step in and prop up private hospitals. This creates an opportunity to invest in Australia’s largest health insurer.

Shares

Negative correlations, positive allocations

A nascent theme today is that the inverse correlation between bonds and stocks has returned as inflation and economic growth moderate. This broadens the potential for risk-adjusted returns in multi-asset portfolios.

Retirement

The secret to a good retirement

An Australian anthropologist studying Japanese seniors has come to a counter-intuitive conclusion to what makes for a great retirement: she suggests the seeds may be found in how we approach our working years.

Sponsors

Alliances

© 2024 Morningstar, Inc. All rights reserved.

Disclaimer
The data, research and opinions provided here are for information purposes; are not an offer to buy or sell a security; and are not warranted to be correct, complete or accurate. Morningstar, its affiliates, and third-party content providers are not responsible for any investment decisions, damages or losses resulting from, or related to, the data and analyses or their use. To the extent any content is general advice, it has been prepared for clients of Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892), without reference to your financial objectives, situation or needs. For more information refer to our Financial Services Guide. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Articles are current as at date of publication.
This website contains information and opinions provided by third parties. Inclusion of this information does not necessarily represent Morningstar’s positions, strategies or opinions and should not be considered an endorsement by Morningstar.